These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 24980431

  • 1. Electrophilic lipid mediator 15-deoxy-Δ12,14-prostaglandin j2 modifies glucocorticoid signaling via receptor SUMOylation.
    Paakinaho V, Kaikkonen S, Levonen AL, Palvimo JJ.
    Mol Cell Biol; 2014 Sep; 34(17):3202-13. PubMed ID: 24980431
    [Abstract] [Full Text] [Related]

  • 2. 15-deoxy-Delta12,14-prostaglandin J2 inhibits glucocorticoid binding and signaling in macrophages through a peroxisome proliferator-activated receptor gamma-independent process.
    Cheron A, Peltier J, Perez J, Bellocq A, Fouqueray B, Baud L.
    J Immunol; 2004 Jun 15; 172(12):7677-83. PubMed ID: 15187150
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
    Ji JD, Kim HJ, Rho YH, Choi SJ, Lee YH, Cheon HJ, Sohn J, Song GG.
    Rheumatology (Oxford); 2005 Aug 15; 44(8):983-8. PubMed ID: 15840591
    [Abstract] [Full Text] [Related]

  • 4. Nrf2-mediated induction of cytoprotective enzymes by 15-deoxy-Delta12,14-prostaglandin J2 is attenuated by alkenal/one oxidoreductase.
    Yu X, Egner PA, Wakabayashi J, Wakabayashi N, Yamamoto M, Kensler TW.
    J Biol Chem; 2006 Sep 08; 281(36):26245-52. PubMed ID: 16857669
    [Abstract] [Full Text] [Related]

  • 5. 15-Deoxy-Δ12,14-prostaglandin J2 activates PI3K-Akt signaling in human breast cancer cells through covalent modification of the tumor suppressor PTEN at cysteine 136.
    Suh J, Kim DH, Kim EH, Park SA, Park JM, Jang JH, Kim SJ, Na HK, Kim ND, Kim NJ, Suh YG, Surh YJ.
    Cancer Lett; 2018 Jun 28; 424():30-45. PubMed ID: 29550515
    [Abstract] [Full Text] [Related]

  • 6. Novel binding sites of 15-deoxy-Delta12,14-prostaglandin J2 in plasma membranes from primary rat cortical neurons.
    Yagami T, Ueda K, Asakura K, Takasu N, Sakaeda T, Itoh N, Sakaguchi G, Kishino J, Nakazato H, Katsuyama Y, Nagasaki T, Okamura N, Hori Y, Hanasaki K, Arimura A, Fujimoto M.
    Exp Cell Res; 2003 Nov 15; 291(1):212-27. PubMed ID: 14597421
    [Abstract] [Full Text] [Related]

  • 7. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
    Chen ZY, Tseng CC.
    Mol Pharmacol; 2005 Nov 15; 68(5):1203-13. PubMed ID: 16077033
    [Abstract] [Full Text] [Related]

  • 8. 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) signals through retinoic acid receptor-related orphan receptor-alpha but not peroxisome proliferator-activated receptor-gamma in human vascular endothelial cells: the effect of 15d-PGJ2 on tumor necrosis factor-alpha-induced gene expression.
    Migita H, Morser J.
    Arterioscler Thromb Vasc Biol; 2005 Apr 15; 25(4):710-6. PubMed ID: 15662020
    [Abstract] [Full Text] [Related]

  • 9. Rac1 modification by an electrophilic 15-deoxy Δ(12,14)-prostaglandin J2 analog.
    Wall SB, Oh JY, Mitchell L, Laube AH, Campbell SL, Renfrow MB, Landar A.
    Redox Biol; 2015 Apr 15; 4():346-54. PubMed ID: 25677088
    [Abstract] [Full Text] [Related]

  • 10. SUMOylation regulates the chromatin occupancy and anti-proliferative gene programs of glucocorticoid receptor.
    Paakinaho V, Kaikkonen S, Makkonen H, Benes V, Palvimo JJ.
    Nucleic Acids Res; 2014 Feb 15; 42(3):1575-92. PubMed ID: 24194604
    [Abstract] [Full Text] [Related]

  • 11. Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells.
    Moriai M, Tsuji N, Kobayashi D, Kuribayashi K, Watanabe N.
    Int J Oncol; 2009 May 15; 34(5):1363-72. PubMed ID: 19360348
    [Abstract] [Full Text] [Related]

  • 12. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
    Sawano H, Haneda M, Sugimoto T, Inoki K, Koya D, Kikkawa R.
    Kidney Int; 2002 Jun 15; 61(6):1957-67. PubMed ID: 12028436
    [Abstract] [Full Text] [Related]

  • 13. Identification of 15d-PGJ2 as an antagonist of farnesoid X receptor: molecular modeling with biological evaluation.
    Xu X, Lu Y, Chen L, Chen J, Luo X, Shen X.
    Steroids; 2013 Sep 15; 78(9):813-22. PubMed ID: 23707573
    [Abstract] [Full Text] [Related]

  • 14. Identification of novel protein targets for modification by 15-deoxy-Delta12,14-prostaglandin J2 in mesangial cells reveals multiple interactions with the cytoskeleton.
    Stamatakis K, Sánchez-Gómez FJ, Pérez-Sala D.
    J Am Soc Nephrol; 2006 Jan 15; 17(1):89-98. PubMed ID: 16291835
    [Abstract] [Full Text] [Related]

  • 15. Physiological and Pathological Roles of 15-Deoxy-Δ12,14-Prostaglandin J2 in the Central Nervous System and Neurological Diseases.
    Yagami T, Yamamoto Y, Koma H.
    Mol Neurobiol; 2018 Mar 15; 55(3):2227-2248. PubMed ID: 28299574
    [Abstract] [Full Text] [Related]

  • 16. Differential effects of serum constituents on apoptosis induced by the cyclopentenone prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in WISH epithelial cells.
    Berry EB, Sato TA, Mitchell MD, Stewart Gilmour R, Helliwell RJ.
    Prostaglandins Leukot Essent Fatty Acids; 2004 Sep 15; 71(3):191-7. PubMed ID: 15253890
    [Abstract] [Full Text] [Related]

  • 17. 15-deoxy-delta12,14-Prostaglandin J2 inhibits tissue factor expression in human macrophages and endothelial cells: evidence for ERK1/2 signaling pathway blockade.
    Eligini S, Banfi C, Brambilla M, Camera M, Barbieri SS, Poma F, Tremoli E, Colli S.
    Thromb Haemost; 2002 Sep 15; 88(3):524-32. PubMed ID: 12353085
    [Abstract] [Full Text] [Related]

  • 18. Upregulation of interleukin-8 expression by prostaglandin D2 metabolite 15-deoxy-delta12, 14 prostaglandin J2 (15d-PGJ2) in human THP-1 macrophages.
    Fu Y, Luo N, Lopes-Virella MF.
    Atherosclerosis; 2002 Jan 15; 160(1):11-20. PubMed ID: 11755918
    [Abstract] [Full Text] [Related]

  • 19. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma.
    Giri S, Rattan R, Singh AK, Singh I.
    J Immunol; 2004 Oct 15; 173(8):5196-208. PubMed ID: 15470065
    [Abstract] [Full Text] [Related]

  • 20. Targeting of epidermal growth factor receptor by cyclopentenone prostaglandin 15-Deoxy-Delta12,14-prostaglandin J2 in human oral squamous carcinoma cells.
    Siavash H, Nikitakis NG, Sauk JJ.
    Cancer Lett; 2004 Jul 28; 211(1):97-103. PubMed ID: 15194221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.